Return to Clinical Trials Search Results

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure - Thrombolysis in Myocardial Infarction 68 ( DAPA ACT HF-TIMI 68)

PRIMARY OBJECTIVE To assess the effect of in©\hospital initiation of dapagliflozin, as compared with placebo, on the clinical outcomes of cardiovascular death or worsening heart failure in patients with heart failure with reduced ejection fraction (LVEF ¡Ü40%) who have been stabilized during hospitalization for acute heart failure To evaluate the safety and tolerability of in hospital initiation of dapagliflozin in this patient population.



Recruitment Status

Current Studies